Diagnostic Electrocardiograph Market by Product (Event Monitors, Holter Monitors, Implantable Loop Recorders), Lead Type (12-lead, 3-lead, 5-lead), End User - Global Forecast 2023-2030
The Diagnostic Electrocardiograph Market is projected to reach USD 17.61 billion by 2030 from USD 10.50 billion in 2022, at a CAGR of 6.68% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Diagnostic Electrocardiograph Market.
- Based on Product, market is studied across Event Monitors, Holter Monitors, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, Resting ECG Devices, Smart ECG Monitors, Software & Services, and Stress ECG Devices. The Stress ECG Devices is projected to witness significant market share during forecast period.
- Based on Lead Type, market is studied across 12-lead, 3-lead, 5-lead, 6-lead, and Single-lead. The 3-lead is projected to witness significant market share during forecast period.
- Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Centers, Diagnostic Centers, Hospitals & Clinics, and Personal User. The Personal User is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 36.79% in 2022, followed by Americas.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Diagnostic Electrocardiograph Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Diagnostic Electrocardiograph Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Diagnostic Electrocardiograph Market, highlighting leading vendors and their innovative profiles. These include ACS Diagnostics, AliveCor, Inc., Ambu A/S, Aspel SA, ATsens Co., Ltd., Auxo Medical LLC, Bionet Co., Inc., BPL Medical Technologies Pvt. Ltd., BTL, Cardioline S.p.A., Cardiologs Technologies, CompuMed, Inc., Custo Med GmbH, Davis Medical Electronics, Inc., Edan Instruments, Inc., Fukuda Denshi Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom, Inc., Innomed Medical Zrt., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Nihon Kohden Corporation, Norav Medical Ltd., OSI Systems, Inc., Schiller AG, Shenzhen Comen Medical Instruments Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Suzuken Co., Ltd., Vectracor, Inc., Viatom Technology Co., Ltd., VYAIRE Medical, Inc., and Zimmer MedizinSysteme GmbH.
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Diagnostic Electrocardiograph Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Diagnostic Electrocardiograph Market?
- What is the competitive strategic window for identifying opportunities in the Diagnostic Electrocardiograph Market?
- What are the latest technology trends and regulatory frameworks in the Diagnostic Electrocardiograph Market?
- What is the market share of the leading vendors in the Diagnostic Electrocardiograph Market?
- Which modes and strategic moves are suitable for entering the Diagnostic Electrocardiograph Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Diagnostic Electrocardiograph Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rapidly Changing Lifestyles Increase the Incidence of Cardiovascular Diseases Worldwide
- 5.1.1.2. Surge in Global Aging Population and Need for Early Diagnosis of Cardiovascular Conditions
- 5.1.1.3. Increasing Development and Adoption of Wearable and Wireless Remote Monitoring Devices
- 5.1.2. Restraints
- 5.1.2.1. Issues with Unfavourable Reimbursement Policies
- 5.1.3. Opportunities
- 5.1.3.1. Emerging Demand from the Developing Economies with Improving Healthcare Infrastructure
- 5.1.3.2. Ongoing Advancements in Diagnostics with Increased Investments
- 5.1.4. Challenges
- 5.1.4.1. Lack of Skilled Expertise to Operate Advanced ECGs
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Diagnostic Electrocardiograph Market, by Product
- 6.1. Introduction
- 6.2. Event Monitors
- 6.3. Holter Monitors
- 6.4. Implantable Loop Recorders
- 6.5. Mobile Cardiac Telemetry Devices
- 6.6. Resting ECG Devices
- 6.7. Smart ECG Monitors
- 6.8. Software & Services
- 6.9. Stress ECG Devices
- 7. Diagnostic Electrocardiograph Market, by Lead Type
- 7.1. Introduction
- 7.2. 12-lead
- 7.3. 3-lead
- 7.4. 5-lead
- 7.5. 6-lead
- 7.6. Single-lead
- 8. Diagnostic Electrocardiograph Market, by End User
- 8.1. Introduction
- 8.2. Ambulatory Surgical Centers
- 8.3. Cardiac Centers
- 8.4. Diagnostic Centers
- 8.5. Hospitals & Clinics
- 8.6. Personal User
- 9. Americas Diagnostic Electrocardiograph Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Diagnostic Electrocardiograph Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Diagnostic Electrocardiograph Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. ACS Diagnostics
- 13.1.2. AliveCor, Inc.
- 13.1.3. Ambu A/S
- 13.1.4. Aspel SA
- 13.1.5. ATsens Co., Ltd.
- 13.1.6. Auxo Medical LLC
- 13.1.7. Bionet Co., Inc.
- 13.1.8. BPL Medical Technologies Pvt. Ltd.
- 13.1.9. BTL
- 13.1.10. Cardioline S.p.A.
- 13.1.11. Cardiologs Technologies
- 13.1.12. CompuMed, Inc.
- 13.1.13. Custo Med GmbH
- 13.1.14. Davis Medical Electronics, Inc.
- 13.1.15. Edan Instruments, Inc.
- 13.1.16. Fukuda Denshi Co., Ltd.
- 13.1.17. GE HealthCare Technologies Inc.
- 13.1.18. Hill-Rom, Inc.
- 13.1.19. Innomed Medical Zrt.
- 13.1.20. Koninklijke Philips N.V.
- 13.1.21. Lepu Medical Technology(Beijing)Co.,Ltd.
- 13.1.22. Nihon Kohden Corporation
- 13.1.23. Norav Medical Ltd.
- 13.1.24. OSI Systems, Inc.
- 13.1.25. Schiller AG
- 13.1.26. Shenzhen Comen Medical Instruments Co., Ltd.
- 13.1.27. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 13.1.28. Suzuken Co., Ltd.
- 13.1.29. Vectracor, Inc.
- 13.1.30. Viatom Technology Co., Ltd.
- 13.1.31. VYAIRE Medical, Inc.
- 13.1.32. Zimmer MedizinSysteme GmbH
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook